Evaxion A (EVAX) Consolidated Net Income (2020 - 2026)
Evaxion A posted quarterly Consolidated Net Income of -$3.4 million for Q1 2026, down 73.01% year-on-year from -$12.6 million in Q1 2025, and down 264.2% on a QoQ basis from -$933000.0 in Q4 2025.
Evaxion A (EVAX) has 7 years of Consolidated Net Income data on file, last reported at -$3.4 million in Q1 2026.
- For the quarter ending Q1 2026, Consolidated Net Income fell 73.01% year-over-year to -$3.4 million; the trailing twelve-month figure through Mar 2026 stood at -$2.7 million (up 81.54% YoY), and the FY2025 full-year result was -$9.5 million, up 21.58% from the prior year.
- Consolidated Net Income for Q1 2026 stood at -$3.4 million, down from -$933000.0 in the prior quarter.
- Across five years, Consolidated Net Income topped out at $6.8 million in Q3 2025 and bottomed at -$7.2 million in Q4 2022.
- The 5-year median for Consolidated Net Income is -$5.1 million (2022), against an average of -$3.8 million.
- Peak annual rise in Consolidated Net Income reached 420.03% in 2025, while the deepest fall reached 359.1% in 2025.
- A 5-year view of Consolidated Net Income shows it stood at -$7.2 million in 2022, then jumped by 32.43% to -$4.9 million in 2023, then grew by 14.31% to -$4.2 million in 2024, then surged by 77.67% to -$933000.0 in 2025, then tumbled by 264.2% to -$3.4 million in 2026.
- The last three Consolidated Net Income figures came in at -$3.4 million (Q1 2026), -$933000.0 (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -8.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.40 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -453.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.40 Mn |
| Dec 31, 2025 | -933,000.00 |
| Sep 30, 2025 | 6.81 Mn |
| Jun 30, 2025 | -5.22 Mn |
| Mar 31, 2025 | -1.96 Mn |
| Dec 31, 2024 | -4.18 Mn |
| Sep 30, 2024 | -2.13 Mn |
| Jun 30, 2024 | -6.60 Mn |
| Mar 31, 2024 | 758,000.00 |
| Dec 31, 2023 | -4.88 Mn |
| Sep 30, 2023 | -6.07 Mn |
| Jun 30, 2023 | -6.13 Mn |
| Mar 31, 2023 | -6.63 Mn |
| Dec 31, 2022 | -7.22 Mn |
| Sep 30, 2022 | -6.09 Mn |
| Jun 30, 2022 | -5.12 Mn |
| Mar 31, 2022 | -6.29 Mn |
| Dec 31, 2021 | -5.72 Mn |
| Sep 30, 2021 | -6.10 Mn |
| Jun 30, 2021 | -8.16 Mn |
| Mar 31, 2021 | -4.91 Mn |
| Dec 31, 2020 | -5.28 Mn |
| Sep 30, 2020 | -5.17 Mn |
| Jun 30, 2020 | -4.23 Mn |
| Mar 31, 2020 | -3.46 Mn |